The Ostase® BAP EIA Assay is an in-vitro device indicated for the quantitative measurement of bone-specific alkaline phosphatase (BAP), an indicator of osteoblastic activity in human serum1,2.
This device is intended to be used as an aid in the management of postmenopausal osteoporosis and Paget’s disease.
Ostase® is a registered trademark of Hybritech Incorporated, a subsidiary of Beckman Coulter, Inc.